(Q50183762)

26 February 2018

title

Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones. (English)

1 reference

26 February 2018

author name string

S Okamoto

1

1 reference

26 February 2018

K Nakano

2

1 reference

26 February 2018

K Kosahara

3

1 reference

26 February 2018

M Kishinaka

4

1 reference

26 February 2018

H Oda

5

1 reference

26 February 2018

H Ichimiya

6

1 reference

26 February 2018

K Chijiiwa

7

1 reference

26 February 2018

S Kuroki

8

1 reference

26 February 2018

publication date

1 February 1994

1 reference

26 February 2018

Journal of Gastroenterology

published in

1 reference

26 February 2018

volume

29

1 reference

26 February 2018

issue

1

1 reference

26 February 2018

page(s)

47-55

1 reference

26 February 2018

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

cites work

1 reference

12 December 2020

Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile

1 reference

12 December 2020

Effects of mevinolin in rat liver: evidence for a lack of coupling between synthesis of hydroxymethylglutaryl-CoA reductase and cholesterol 7 alpha-hydroxylase activity.

1 reference

12 December 2020

Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption

1 reference

12 December 2020

Lovastatin treatment inhibits sterol synthesis and induces HMG-CoA reductase activity in mononuclear leukocytes of normal subjects

1 reference

12 December 2020

Effects of pravastatin (CS-514) on biliary lipid metabolism in patients with hyperlipidemia

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia

1 reference

12 December 2020

Microanalysis of bile acid in human liver tissue by selected ion monitoring

1 reference

12 December 2020

Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism

1 reference

12 December 2020

Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones

1 reference

12 December 2020

Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase

1 reference

12 December 2020

Improved method for simultaneous determination of cholesterol in high- and low-density lipoproteins

1 reference

12 December 2020

Phosphorus assay in column chromatography

1 reference

12 December 2020

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

1 reference

12 December 2020

A receptor-mediated pathway for cholesterol homeostasis

1 reference

12 December 2020

A simple and sensitive assay of total serum bile acids

1 reference

12 December 2020

Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans

1 reference

12 December 2020

Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.

1 reference

12 December 2020

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

1 reference

12 December 2020

Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients

1 reference

12 December 2020

Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones

1 reference

12 December 2020

Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease

1 reference

12 December 2020

Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.

1 reference

12 December 2020

Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolaemia

1 reference

12 December 2020

Increase in serum and bile cholesterol and HMG-CoA reductase by lovastatin in rats

1 reference

12 December 2020

Regulation of bile acid synthesis. IV. Interrelationship between cholesterol and bile acid biosynthesis pathways

1 reference

12 December 2020

Esterified and total 7 alpha-hydroxycholesterol in human serum as an indicator for hepatic bile acid synthesis

1 reference

12 December 2020

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

12 December 2020

Effect of CS-514, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in hamsters

1 reference

12 December 2020

The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolemic subjects

1 reference

12 December 2020

Influence of the HMG-CoA-reductase inhibitor lovastatin on cholesterol saturation index and nucleation time of duodenal bile.

1 reference

12 December 2020

Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase

1 reference

12 December 2020

Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation.

1 reference

12 December 2020

Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.

1 reference

12 December 2020

Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans

1 reference

12 December 2020

Rapid computation with the personal computer of the percent cholesterol saturation of bile samples

1 reference

12 December 2020

Assay of cholesterol 7 alpha-hydroxylase utilizing a silica cartridge column and 5 alpha-cholestane-3 beta, 7 beta-diol as an internal standard

1 reference

12 December 2020

Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Simultaneous microanalysis of bile acids and cholesterol in bile by glass capillary column gas chromatography

1 reference

12 December 2020

Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 alpha-hydroxylase activity

1 reference

12 December 2020

Simultaneous assay of the activities of two key enzymes in cholesterol metabolism by gas chromatography-mass spectrometry

1 reference

12 December 2020

Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01229073

1 reference

26 February 2018

1 reference

26 February 2018